Report finds Americans with long COVID losing billions in wages, as Moderna sues Pfizer and BioNTech over mRNA patents
Some 16 million Americans of working age have long-term COVID and as many as 4…
Read MoreSome 16 million Americans of working age have long-term COVID and as many as 4…
Read MoreModerna Inc. MRNA, -1.49% said Friday it is suing Pfizer Inc. PFE, -1.06% and German…
Read MoreAmericans age 12 and older could begin getting omicron-specific COVID-19 boosters soon after Labor Day,…
Read MoreModerna Inc. Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic…
Read MoreModerna MRNA, +3.81% and Pfizer PFE, -0.41% have not yet started clinical trials for the…
Read MoreA new, highly infectious subvariant of omicron is raising concerns among scientists and health experts…
Read MoreA new, highly infectious subvariant of omicron is raising concerns among scientists and health experts…
Read More